Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial

Saip P., Eralp Y., Sen F., Karaca H., Ozkan M., Cetin B., ...More

BREAST, vol.22, no.5, pp.628-633, 2013 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 5
  • Publication Date: 2013
  • Doi Number: 10.1016/j.breast.2013.07.048
  • Title of Journal : BREAST
  • Page Numbers: pp.628-633


Background: The aim of this explorative phase II study was to evaluate the activity and safety of lapatinib in combination with intravenous vinorelbine in women with HER2 positive metastatic or recurrent breast cancer.